Clinical trials of parenteral antineoplastic agents.
Parenteral antineoplastic regimens are being administered in a variety of healthcare settings. Clinical trials play an important role in the development and testing of these regimens. An update on the role of clinical trials in identifying new agents to combat cancer is provided. Nursing considerations, patient selection, and disease-specific criteria are discussed.
Division of Cancer Treatment, National Institutes of Health National Cancer Institute, USA.
G
G
Cusack
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002985:Clinical Protocols; D002986:Clinical Trials as Topic / Q000451:nursing; D004353:Drug Evaluation, Preclinical; D006801:Humans; D007262:Infusions, Intravenous / Q000451:nursing; D009369:Neoplasms / Q000188:drug therapy / Q000451:nursing; D009859:Oncology Nursing / Q000379:methods; D018579:Patient Selection
D000970:Antineoplastic Agents